Emerging Therapies for CAD/PAD: Reducing the Risk of Secondary Thrombotic Events

Overview

Intended Audience: Care teams of physicians, NPs, PAs, nurses, and pharmacists specializing in cardiology, internal medicine, or primary care.

Substantial advances offer new tools for patients with peripheral artery disease (PAD) or coronary artery disease (CAD). However, these new developments bring challenges, including complexity of treatment decision-making to minimize the risk of secondary thrombotic events.

Listen in as our expert panel reviews:

Strategies to identify patients at high risk for secondary thrombotic events
The latest clinical data on current and emerging therapies

This webinar is delivered in partnership with the Society for Vascular Medicine and Mended Hearts.

Learning Objectives

Describe pathophysiology and underlying disease mechanisms of peripheral artery disease (PAD) and coronary artery disease (CAD)
Evaluate clinical data on the safety and efficacy of current and emerging PAD and CAD treatments
Implement evidence-based strategies to reduce the risk of acute vascular and limb events related to PAD and CAD

Agenda

Identifying PAD/CAD Patients at High Risk of Secondary Thrombotic Events
New Clinical Data on Current and Emerging Therapies for PAD and CAD
Applying Effective Evidence-Based Strategies to Reduce Risks Associated With PAD and CAD

Faculty

Matthew T Menard, MD

Speaker

Associate Professor of Surgery
Harvard Medical School
Co-Director, Endovascular Surgery
Brigham and Women's Hospital
Boston, MA

Manesh R Patel, MD

Speaker

Richard S Stack Distinguished Professor of Medicine
Chief, Division of Cardiology
Co-Director, Duke Heart Center
Duke University School of Medicine
Durham, NC

Ali M Moran, DNP, AGACNP

Moderator

Vascular Medicine Nurse Practitioner
Division of Cardiovascular Medicine
Vanderbilt University Medical Center
Nashville, TN

Beth Augee

Contributing Author

Heart Patient Advocate
Salem, OR

Marvin Keyser

Contributing Author

Heart Patient Advocate
Weston, FL

Marc P Bonaca, MD, MPH, FAHA, FACC

Course Director

Professor of Medicine
Director, Vascular Research
University of Colorado Anschutz Medical Campus
Aurora, CO

Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP

Planner

Adjunct Faculty & Preceptor
Albany College of Pharmacy
Albany, NY

Henry A Solomon, MD, FACP, FACC

Planner

Cardiologist and Internal Medicine Physician
New York, NY

Joyce M Knestrick, PhD, CRNP, FAANP

Peer Reviewer

Visiting Professor
George Washington University
Family Nurse Practitioner
Wheeling Health Right
Wheeling, WV

CE Details & Instructions

Joint Accreditation Statement

In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional Teams

This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement

PRIME® designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Physician Assistant Accreditation Statement

PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner Accreditation Statement

Nurse Practitioner Logo PRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0 hour of pharmacology).

Pharmacist Accreditation Statement

This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-21-195-L01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service ([email protected]).

Nurse Accreditation Statement

PRIME® designates this activity for 1.0 contact hour.

Obtaining CE Credit

Register using the online form
Complete the pre-registration survey
Attend the live program in its entirety
Complete an online evaluation and post-test
Download and/or print a certificate of completion and/or submit CE credits electronically

Instructions to access CME/CE credit options will be provided at the end of the program.

Method of Participation

This live CME/CE activity requires attendance of the participant during the entire program and completion of learner assessment tools. The learner will then receive instructions on how to download and/or print a certificate of completion and/or submit CE credits electronically.

Device Requirements

Hardware: an Internet-enabled computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity
Software: the installation of software such as GoToWebinar may be required

Faculty Disclosures

*PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with commercial interests to disclose:

Matthew T Menard, MD (Speaker)

Advisory Board or Panel – Janssen
Manesh R Patel, MD (Speaker)

Advisory Board or Panel – Bayer, Heartflow, Janssen, Novartis
Consultant – Bayer, Janssen
Grants / Research Support – Bayer, Heartflow, Janssen, NHLBI, Novartis
Marc P Bonaca, MD, MPH, FAHA, FACC (Course Director, Speaker)

Grants / Research Support – ARCA BioPharma, Amgen, AstraZeneca/Medimmune, Bayer, Better Therapeutics, Everywell, Janssen, Novo Nordisk

The following individuals have no relevant financial relationships with commercial interests to disclose:

Ali M Moran, DNP, AGACNP (Moderator)
Beth Augee (Author)
Marvin Keyser (Author)
Joyce M Knestrick, PhD, CRNP, FAANP (Reviewer)
Donna M Chiefari, BSc (Pharm), PharmD, RPh, FASHP (Planner)
Henry A Solomon, MD, FACP, FACC (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose.

Funding Disclosure

This activity is provided by PRIME Education. There is no fee to participate. This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Accessibility Statement

At PRIME, we are committed to ensuring that individuals with disabilities can access all of the content offered by PRIME through our website and other properties. If you are having trouble accessing primeinc.org, please email [email protected] for assistance. Please put "ADA Inquiry" in the subject line of your email.

Summary


Cost:	FREE


Credit:	No Credit Offered

Create Account